1. National Institute for Health and Care Excellence. Appraisal consultation document. Cannabidiol with clobazam for treating seizures associated with Lennox-Gastaut Syndrome. Aug 2019.
2. National Institute for Health and Care Excellence. Appraisal consultation document. Cannabidiol with clobazam for treating seizures associated with Dravet. Aug 2019.
3. Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
4. Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial
5. US Food and Drug Administration. Drug approval package: Epidiolex (Cannabidiol). https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210365Orig1s000TOC.cfm.